Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Stefan J Barfeld"'
Autor:
Alfonso Urbanucci, Stefan J. Barfeld, Ville Kytölä, Harri M. Itkonen, Ilsa M. Coleman, Daniel Vodák, Liisa Sjöblom, Xia Sheng, Teemu Tolonen, Sarah Minner, Christoph Burdelski, Kati K. Kivinummi, Annika Kohvakka, Steven Kregel, Mandeep Takhar, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Paul Lloyd, R. Jeffrey Karnes, Ashley E. Ross, Edward M. Schaeffer, Donald J. Vander Griend, Stefan Knapp, Eva Corey, Felix Y. Feng, Peter S. Nelson, Fahri Saatcioglu, Karen E. Knudsen, Teuvo L.J. Tammela, Guido Sauter, Thorsten Schlomm, Matti Nykter, Tapio Visakorpi, Ian G. Mills
Publikováno v:
Cell Reports, Vol 19, Iss 10, Pp 2045-2059 (2017)
Global changes in chromatin accessibility may drive cancer progression by reprogramming transcription factor (TF) binding. In addition, histone acetylation readers such as bromodomain-containing protein 4 (BRD4) have been shown to associate with thes
Externí odkaz:
https://doaj.org/article/a031c1acff234116bfd1c096aa18acae
Autor:
Stefan J. Barfeld, Alfonso Urbanucci, Harri M. Itkonen, Ladan Fazli, Jessica L. Hicks, Bernd Thiede, Paul S. Rennie, Srinivasan Yegnasubramanian, Angelo M. DeMarzo, Ian G. Mills
Publikováno v:
EBioMedicine, Vol 18, Iss C, Pp 83-93 (2017)
Prostate cancer (PCa) is the most common non-cutaneous cancer in men. The androgen receptor (AR), a ligand-activated transcription factor, constitutes the main drug target for advanced cases of the disease. However, a variety of other transcription f
Externí odkaz:
https://doaj.org/article/9991520fd4b04e2080ac059491b62c2d
Autor:
Jens Preben Morth, Cinzia Progida, Hanne Guldsten, Ian G. Mills, Oddmund Bakke, Stefan J Barfeld, Magnus Ø. Arntzen, Harmonie Perdreau-Dahl, Bernd Thiede, Stefan Krauss
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-11 (2020)
Perdreau-Dahl, H, Progida, C, Barfeld, S J, Guldsten, H, Thiede, B, Arntzen, M, Bakke, O, Mills, I G, Krauss, S & Morth, J P 2020, ' Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells ', Communications Biology, vol. 3, no. 1, pp. 123 . https://doi.org/10.1038/s42003-020-0851-2
Communications Biology
Communications biology 3(1), 123 (2020). doi:10.1038/s42003-020-0851-2
'Communications Biology ', vol: 3, pages: 123-1-123-11 (2020)
Perdreau-Dahl, H, Progida, C, Barfeld, S J, Guldsten, H, Thiede, B, Arntzen, M, Bakke, O, Mills, I G, Krauss, S & Morth, J P 2020, ' Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells ', Communications Biology, vol. 3, no. 1, 123 . https://doi.org/10.1038/s42003-020-0851-2
Perdreau-Dahl, H, Progida, C, Barfeld, S J, Guldsten, H, Thiede, B, Arntzen, M, Bakke, O, Mills, I G, Krauss, S & Morth, J P 2020, ' Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells ', Communications Biology, vol. 3, no. 1, pp. 123 . https://doi.org/10.1038/s42003-020-0851-2
Communications Biology
Communications biology 3(1), 123 (2020). doi:10.1038/s42003-020-0851-2
'Communications Biology ', vol: 3, pages: 123-1-123-11 (2020)
Perdreau-Dahl, H, Progida, C, Barfeld, S J, Guldsten, H, Thiede, B, Arntzen, M, Bakke, O, Mills, I G, Krauss, S & Morth, J P 2020, ' Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells ', Communications Biology, vol. 3, no. 1, 123 . https://doi.org/10.1038/s42003-020-0851-2
Communications biology 3(1), 123 (2020). doi:10.1038/s42003-020-0851-2
Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1) was first described as an auto-antigen over-expressed in Sjögren’s syndrome and in scleroderma patients. SSSCA1 has be
Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1) was first described as an auto-antigen over-expressed in Sjögren’s syndrome and in scleroderma patients. SSSCA1 has be
Autor:
Mandeep Takhar, Alfonso Urbanucci, Stefan Knapp, Christoph Burdelski, Sarah Minner, Ian G. Mills, Stefan J Barfeld, Ilsa Coleman, Elai Davicioni, Guido Sauter, Teemu Tolonen, Felix Y. Feng, Daniel Vodak, Ashley E. Ross, Teuvo L.J. Tammela, Karen E. Knudsen, Mohammed Alshalalfa, Edward M. Schaeffer, Thorsten Schlomm, Matti Nykter, Tapio Visakorpi, Paul Lloyd, Peter S. Nelson, Nicholas Erho, Annika Kohvakka, Donald J. Vander Griend, Ville Kytölä, Kati Kivinummi, Fahri Saatcioglu, Harri M. Itkonen, Xia Sheng, Liisa Sjöblom, Steven Kregel, Eva Corey, R. Jeffrey Karnes
Publikováno v:
Cell Reports, Vol 19, Iss 10, Pp 2045-2059 (2017)
Cell reports, vol 19, iss 10
Urbanucci, A, Barfeld, S J, Kytölä, V, Itkonen, H M, Coleman, I M, Vodák, D, Sjöblom, L, Sheng, X, Tolonen, T, Minner, S, Burdelski, C, Kivinummi, K K, Kohvakka, A, Kregel, S, Takhar, M, Alshalalfa, M, Davicioni, E, Erho, N, Lloyd, P, Karnes, R J, Ross, A E, Schaeffer, E M, Vander Griend, D J, Knapp, S, Corey, E, Feng, F Y, Nelson, P S, Saatcioglu, F, Knudsen, K E, Tammela, T L J, Sauter, G, Schlomm, T, Nykter, M, Visakorpi, T & Mills, I G 2017, ' Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer ', Cell Reports, vol. 19, no. 10, pp. 2045-2059 . https://doi.org/10.1016/j.celrep.2017.05.049
Cell reports, vol 19, iss 10
Urbanucci, A, Barfeld, S J, Kytölä, V, Itkonen, H M, Coleman, I M, Vodák, D, Sjöblom, L, Sheng, X, Tolonen, T, Minner, S, Burdelski, C, Kivinummi, K K, Kohvakka, A, Kregel, S, Takhar, M, Alshalalfa, M, Davicioni, E, Erho, N, Lloyd, P, Karnes, R J, Ross, A E, Schaeffer, E M, Vander Griend, D J, Knapp, S, Corey, E, Feng, F Y, Nelson, P S, Saatcioglu, F, Knudsen, K E, Tammela, T L J, Sauter, G, Schlomm, T, Nykter, M, Visakorpi, T & Mills, I G 2017, ' Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer ', Cell Reports, vol. 19, no. 10, pp. 2045-2059 . https://doi.org/10.1016/j.celrep.2017.05.049
Global changes in chromatin accessibility may drive cancer progression by reprogramming transcription factor (TF) binding. In addition, histone acetylation readers such as bromodomain-containing protein 4 (BRD4) have been shown to associate with thes
Autor:
Srinivasan Yegnasubramanian, Alfonso Urbanucci, Bernd Thiede, Jessica L. Hicks, Ladan Fazli, Angelo M. DeMarzo, Harri M. Itkonen, Ian G. Mills, Stefan J Barfeld, Paul S. Rennie
Publikováno v:
EBioMedicine
Barfeld, S J, Urbanucci, A, Itkonen, H M, Fazli, L, Hicks, J L, Thiede, B, Rennie, P S, Yegnasubramanian, S, DeMarzo, A M & Mills, I G 2017, ' c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks ', EBioMedicine, vol. 18, pp. 83-93 . https://doi.org/10.1016/j.ebiom.2017.04.006
EBioMedicine, Vol 18, Iss C, Pp 83-93 (2017)
Barfeld, S J, Urbanucci, A, Itkonen, H M, Fazli, L, Hicks, J L, Thiede, B, Rennie, P S, Yegnasubramanian, S, DeMarzo, A M & Mills, I G 2017, ' c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks ', EBioMedicine, vol. 18, pp. 83-93 . https://doi.org/10.1016/j.ebiom.2017.04.006
EBioMedicine, Vol 18, Iss C, Pp 83-93 (2017)
Prostate cancer (PCa) is the most common non-cutaneous cancer in men. The androgen receptor (AR), a ligand-activated transcription factor, constitutes the main drug target for advanced cases of the disease. However, a variety of other transcription f
Autor:
Tapio Visakorpi, Mohammed Alshalalfa, Edward M. Schaeffer, Guido Sauter, Sarah Minner, Stefan J Barfeld, R. Jeffrey Karnes, Liisa Sjöblom, Kati Kivinummi, Steven Kregel, Alfonso Urbanucci, Elai Davicioni, Ville Kytölä, Daniel Vodak, Teuvo L.J. Tammela, Teemu Tolonen, Stefan Knapp, Thorsten Schlomm, Ashley E. Ross, Ian G. Mills, Griend Donald J. Vander, Matti Nykter, Mandeep Takhar, Nicholas Erho, Christoph Burdelski
Publikováno v:
Endocrine Abstracts.
Autor:
Stefan J, Barfeld, Ian G, Mills
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1443
Chromatin immunoprecipitation (ChIP) provides a means of enriching DNA associated with transcription factors, histone modifications, and indeed any other proteins for which suitably characterized antibodies are available. Over the years, sequence det
Autor:
Ian G. Mills, Stefan J Barfeld
Publikováno v:
Methods in Molecular Biology ISBN: 9781493937226
Barfeld, S J & Mills, I G 2016, Mapping Protein-DNA Interactions Using ChIP-exo and Illumina-Based Sequencing . in I J McEwan (ed.), The Nuclear Receptor Superfamily: methods and protocols Part III . vol. 1443, Methods in Molecular Biology, vol. 1443, Springer, New York, pp. 119-137 . https://doi.org/10.1007/978-1-4939-3724-0_8
Barfeld, S J & Mills, I G 2016, Mapping Protein-DNA Interactions Using ChIP-exo and Illumina-Based Sequencing . in I J McEwan (ed.), The Nuclear Receptor Superfamily: methods and protocols Part III . vol. 1443, Methods in Molecular Biology, vol. 1443, Springer, New York, pp. 119-137 . https://doi.org/10.1007/978-1-4939-3724-0_8
Chromatin immunoprecipitation (ChIP) provides a means of enriching DNA associated with transcription factors, histone modifications, and indeed any other proteins for which suitably characterized antibodies are available. Over the years, sequence det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ff3202574d88a28793152600c6929b
https://doi.org/10.1007/978-1-4939-3724-0_8
https://doi.org/10.1007/978-1-4939-3724-0_8
Autor:
Yvonne Ceder, Andrei Chabes, Paul S. Rennie, Kirsi M. Kaukoniemi, Alfonso Urbanucci, Ian G. Mills, Lisette Marjavaara, Margareta Persson, Tapio Visakorpi, Ladan Fazli, Stefan J Barfeld
Publikováno v:
Oncotarget; 6(14), pp 12587-12602 (2015)
Barfeld, S J, Fazli, L, Persson, M, Marjavaara, L, Urbanucci, A, Kaukoniemi, K M, Rennie, P S, Ceder, Y, Chabes, A, Visakorpi, T & Mills, I G 2015, ' Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer ', Oncotarget, vol. 6, no. 14, pp. 12587-602 . https://doi.org/10.18632/oncotarget.3494
Oncotarget
Barfeld, S J, Fazli, L, Persson, M, Marjavaara, L, Urbanucci, A, Kaukoniemi, K M, Rennie, P S, Ceder, Y, Chabes, A, Visakorpi, T & Mills, I G 2015, ' Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer ', Oncotarget, vol. 6, no. 14, pp. 12587-602 . https://doi.org/10.18632/oncotarget.3494
Oncotarget
The androgen receptor is a key transcription factor contributing to the development of all stages of prostate cancer (PCa). In addition, other transcription factors have been associated with poor prognosis in PCa, amongst which c-Myc (MYC) is a well-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::556bfb3b4e1211c14e5af8beb05e25fb
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-101879
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-101879
Publikováno v:
Endocrine-related cancer. 21(4)
Metabolic changes are a well-described hallmark of cancer and are responses to changes in the activity of diverse oncogenes and tumour suppressors. For example, steroid hormone biosynthesis is intimately associated with changes in lipid metabolism an